Acquisition of APIRx

For personal use only APIRX Leadership Team George Anastassov, MD DDS, MBA Co-founder and CEO Dr. Anastassov is responsible for the Company's commercial operations, strategic decision-making, and oversight of all clinical development assets. He is one of the developers of the first-in-the- world cannabinoid-containing chewing gum-based delivery system among a number of other systems and formulations. Previously, he was CEO and Co-founder of AXIM Biotechnologies, driving market capitalization to over US$ 1.2B. Advisors Professor Dr. John Zajicek MD PhD Univ. of St. Andrews, UK John's diverse and extensive medical honours and experience includes: MD, Cambridge and St. Mary's Hospital PhD, Cell Biology at Cambridge and Professor of Medicine at University of St Andrew's. He is the Chief Investigator in several large multicentre trials, including the cannabinoid use to slow neurodegeneration. John has Authored many papers on cannabinoids, multiple sclerosis, Alzheimer's and Parkinson's diseases. AW Incannex Lekhram Changoer, MSc Co-founder and COO Mr. Changoer is responsible for the Company's R&D, clinical & product development, commercial operations, quality assurance and Sales & Marketing of technical, consumer healthcare and pharmaceutical products. He has co-developed several patents in the cannabinoid field. Previously, he was CTO and Co-founder of AXIM Biotechnologies, driving market capitalization to over US$ 1.2B. Renger Witkamp, PhD University of Wageningen, NL Professor and chair in Nutrition and Pharmacology, combining research and teaching in medical nutrition and the interfaces between foods and medicines. PhD from the University of Utrecht (the Netherlands). His research interests focus on the role of nutrition in determining physiological resilience and the adaptive response of the body (gut, muscle and brain) to ageing, chronic disease and exercise. Dr. Arno Hazekamp, PhD Cannabis Researcher, NL Eric H. Kim, MBA CFO Mr. Kim is responsible for the Company's financial strategy and corporate development. His prior experience includes Corporate Finance at Google, Inc., Investment Banking at Bank of America Merrill Lynch and Lumos Partners, and CEO of ELK Partners. Mr. Kim earned his MBA from The Wharton School at the University of Pennsylvania and is a member of American Mensa. An internationally acclaimed cannabis researcher, and former Head of Research and Education at Bedrocan BV - the official grower of medicinal cannabis in the Netherlands. Arno earned his Bachelor's degree in Molecular Biology, followed by an MSc and PhD degree in Biopharmaceutical Sciences at Leiden University, the Netherlands. Specialist in quality control, product development and clinical trial design for the Dutch national medicinal cannabis program. An active international lecturer and medicinal cannabis advocate, and creator of the annual Masterclass Medicinal Cannabis. Dr. Marcus Meinardi Mauritsclinics, NL Dr. Marcus Meinardi has been working as a dermatologist at the Mauritskliniek, The Hague since 2005. He studied medicine in Rotterdam and then trained as a dermatologist at the University of Amsterdam. In 1992 he became head of the department of dermatology and allergology. Dr. Meinardi has a PhD in research into the treatment of psoriasis. Dr. Meinardi has specialized in dermatology in allergology and allergic reactions of the skin. Shareholder Presentation 10

View entire presentation